Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilla B Holst

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Neuroscience|April 9, 2015
Outer brain barriers in rat and human developmentChristian B Brøchner, Camilla B Holst, Kjeld Møllgård
Scientific Reports|September 16, 2017
Brain barriers and functional interfaces with sequential appearance of ABC efflux transporters during human developmentKjeld Møllgård, Katarzyna M Dziegielewska, Camilla B Holst, et al.
Oncotarget|February 23, 2018
Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trialMogens K Boisen, Camilla B Holst, Nicola Consalvo, et al.
Nature Communications|December 21, 2018
Author Correction: BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicityRikke D Rasmussen, Madhavsai K Gajjar, Lucie Tuckova, et al.
Nature Communications|November 16, 2016
BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicityRikke D Rasmussen, Madhavsai K Gajjar, Lucie Tuckova, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Neuroscience|April 9, 2015
Outer brain barriers in rat and human developmentChristian B Brøchner, Camilla B Holst, Kjeld Møllgård
Scientific Reports|September 16, 2017
Brain barriers and functional interfaces with sequential appearance of ABC efflux transporters during human developmentKjeld Møllgård, Katarzyna M Dziegielewska, Camilla B Holst, et al.
Oncotarget|February 23, 2018
Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trialMogens K Boisen, Camilla B Holst, Nicola Consalvo, et al.
Nature Communications|December 21, 2018
Author Correction: BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicityRikke D Rasmussen, Madhavsai K Gajjar, Lucie Tuckova, et al.
Nature Communications|November 16, 2016
BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicityRikke D Rasmussen, Madhavsai K Gajjar, Lucie Tuckova, et al.
Pageof 1